Consun Pharmaceutical Group Ltd represents values of innovation, integrity, and excellence, as well as a strong commitment to quality healthcare. The company's corporate philosophy focuses on meeting the healthcare needs of individuals and communities by providing safe and effective pharmaceutical products. Consun Pharmaceutical Group Ltd emphasizes research and development, constantly striving to introduce new and improved treatments to enhance people's wellbeing. By maintaining the highest standards of ethical conduct and social responsibility, Consun Pharmaceutical Group Ltd has become a trusted name in the industry. With its dedication to delivering top-quality healthcare solutions, the company aims to improve the quality of life for patients worldwide.

Consun Pharmaceutical Group Ltd is primarily present in China, where it is based. As a leading pharmaceutical company, Consun focuses on research, development, manufacturing, and sales of innovative medicines and healthcare products. With a strong presence in the Chinese market, Consun has established a wide distribution network across various regions within China. The company's commitment to delivering high-quality healthcare solutions has contributed to its success and growth within the Chinese pharmaceutical industry.

Consun Pharmaceutical Group Ltd has achieved several significant milestones. The company successfully obtained Good Manufacturing Practice (GMP) certification, indicating its adherence to quality standards. It has also expanded its product portfolio and established strong market presence in both domestic and international markets. Consun Pharmaceutical Group Ltd has consistently reported steady revenue growth and secured strategic partnerships with leading pharmaceutical companies. Additionally, the company has invested in research and development, leading to the launch of innovative and high-quality pharmaceutical products. Through its commitment to excellence and continuous growth, Consun Pharmaceutical Group Ltd has positioned itself as a reputable player in the pharmaceutical industry.

Consun Pharmaceutical Group Ltd is a renowned pharmaceutical company with a rich history and background. Founded in 1983, the company has grown to become a leading provider of high-quality and innovative healthcare solutions. Consun Pharmaceutical Group Ltd has established itself as a trusted name in the industry, focusing on research, development, production, and marketing of traditional Chinese medicines, chemical drugs, biologics, and other pharmaceutical products. With a commitment to excellence, the company has achieved significant milestones in the field of pharmaceuticals, catering to the healthcare needs of people worldwide. Consun Pharmaceutical Group Ltd's dedication to innovation and quality makes it a reliable player in the global pharmaceutical market.

The main competitors of Consun Pharmaceutical Group Ltd in the market include Pfizer Inc., Johnson & Johnson, Novartis AG, and Roche Holding AG.

Consun Pharmaceutical Group Ltd is primarily active in the pharmaceutical industry. With a focus on research, development, manufacturing, and marketing of pharmaceutical products, Consun Pharmaceutical Group Ltd operates within the healthcare sector. This Chinese company specializes in producing and distributing both modern Western medicines and traditional Chinese medicines. Consun Pharmaceutical Group Ltd aims to provide high-quality and affordable healthcare solutions to the global market.

Consun Pharmaceutical Group Ltd is a leading pharmaceutical company, specializing in the research, development, production, and sale of modern Chinese medicines. The core of their business model lies in integrating traditional Chinese medicine with advanced pharmaceutical technologies. Consun Pharmaceutical Group Ltd focuses on the production and distribution of prescription drugs, over-the-counter drugs, and healthcare products. By leveraging their strong research and development capabilities, they strive to deliver high-quality pharmaceutical products that cater to the healthcare needs of individuals. With a customer-centric approach, Consun Pharmaceutical Group Ltd continues to enhance their product offerings while maintaining their commitment to improving the overall well-being of the community.

De Consun Pharmaceutical Group K/W is 6,29.

De Consun Pharmaceutical Group KUV is 1,91.

De AlleAktien Kwaliteitsscore voor Consun Pharmaceutical Group is 10/10.

De verwachte Consun Pharmaceutical Group omzet is 2,98 mld. CNY.

De verwachte Consun Pharmaceutical Group winst is 901,94 mln. CNY.

The Consun Pharmaceutical Group Ltd is a Chinese company specializing in the manufacturing and sale of pharmaceutical products, as well as the development of medical technologies. The company operates in three main divisions: Pharmaceuticals, Medical Devices, and Health Services. The Pharmaceuticals division includes the production and sale of pharmaceutical products, including prescription drugs, over-the-counter medications, and health products. The company produces a wide range of medicines, including drugs for the treatment of cardiovascular diseases, diabetes, cancer, infectious diseases, and other conditions. Additionally, Consun also offers alternative medicine products based on oriental healing methods and natural ingredients. The second division, Medical Devices, produces and sells medical equipment and devices such as ultrasound machines, X-ray machines, CT scanners, and other medical instruments. The company has a strong presence in the Chinese market and is striving for further international expansion. Finally, Consun offers health services, including health and wellness programs, medical examinations and diagnostics, hospital administration, and pharmaceutical research and development. There is a network of health centers and clinics throughout China that provide consultations, examinations, and treatments. In terms of research and development, Consun is constantly working to develop innovative technologies and therapies, particularly in the field of cancer drugs and personalized medicine. The company has a strong and growing presence in the international research and development sector and actively collaborates with various institutions and universities. In summary, Consun Pharmaceutical Group Ltd offers a wide range of products and services in the healthcare field, including pharmaceutical products, medical devices, and health services. The company has a strong presence in the Chinese market and is striving for further international expansion. Finally, Consun aims to be innovative and develop new technologies and therapies.

Consun Pharmaceutical Group keert een dividend van 0,20 CNY uit, verdeeld over betalingen per jaar.

De dividend kan momenteel niet worden berekend voor Consun Pharmaceutical Group of het bedrijf keert geen dividend uit.

De ISIN van Consun Pharmaceutical Group is KYG2524A1031.

Het WKN van Consun Pharmaceutical Group is A1XAEC.

De ticker van Consun Pharmaceutical Group is 1681.HK.

Binnen de laatste 12 maanden betaalde Consun Pharmaceutical Group een dividend van 0,45 CNY . Dit komt overeen met een dividendrendement van ongeveer 6,33 %. Voor de komende 12 maanden zal Consun Pharmaceutical Group naar verwachting een dividend van 0,52 CNY betalen.

De dividendrendement van Consun Pharmaceutical Group is momenteel 6,33 %.

Consun Pharmaceutical Group betaalt elk kwartaal een dividend uit. Dit wordt uitgekeerd in de maanden juli, oktober, juli, oktober.

Consun Pharmaceutical Group betaalde de afgelopen 13 jaar elk jaar dividend.

Voor de komende 12 maanden wordt een dividend van 0,52 CNY verwacht. Dit komt overeen met een dividendrendement van 7,32 %.

Consun Pharmaceutical Group wordt toegewezen aan de sector 'Gezondheid'.

Om het laatste dividend van Consun Pharmaceutical Group van 20-9-2024 ter hoogte van 0,3 CNY te ontvangen, moest je het aandeel voor de ex-datum op 5-9-2024 in je portefeuille hebben.

De laatste dividenduitkering vond plaats op 20-9-2024.

In het jaar 2023 heeft Consun Pharmaceutical Group 0,2 CNY aan dividenden uitgekeerd.

De dividenden van Consun Pharmaceutical Group worden in CNY uitgekeerd.